For the growth of any business, the persuasive Anthelmintics market research report plays very imperative role. This market report encompasses the study about the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, possible future trends, and market demand and supply scenarios. Anthelmintics market report comprises of a chapter on the global market and all of its associated companies with their profiles, which gives important information and data pertaining to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies.
Data Bridge Market Research analyses that the anthelmintics market was valued at USD 2,846.90 million in 2021 and is expected to reach USD 5,435.60 million by 2029, registering a CAGR of 8.42% during the forecast period of 2022 to 2029.
Download Exclusive Sample (350 Pages PDF) Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-anthelmintics-market
Market Overview:
Anthelmintics are medications that destroy helminths. Flukes, roundworms, and tapeworms are helminth parasites that look like worms. Anthelmintics must be selectively harmful to the parasite rather than the host. Some work by interfering with metabolic processes that are essential to the parasite but not to the host. Other anthelmintics are poorly absorbed via the gut, exposing the parasite to significantly higher anthelmintic concentrations than the host. The parasite is then expelled or digested after starvation or paralysis.
Anthelmintics Market Dynamics
Drivers
Increasing prevalence of helminth infections
The rising prevalence of helminth infections caused by roundworm, whipworm, hookworm, and other worms is anticipated to drive the growth of the anthelmintics market. Various parasitic worm species cause soil-transmitted helminth infections. According to the WHO, about 1.5 billion people worldwide were infected with soil-transmitted helminths as of March 2020. Ascaris lumbricoides (roundworms), trichuris trichiura (whipworms), necator americanus, and ancylostoma duodenale are some of the major disease-causing species (hookworms). Furthermore, S. stercoralis is thought to harm roughly 600 million people worldwide. Other variables that increase the occurrence of soil-transmitted helminth infections around the world include poor hygiene and sanitation.
Some of the major players operating in the anthelmintics market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Merck & Co., Inc. (US)
- Allergan (Ireland)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-anthelmintics-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475